# Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-patients-with-organ-dysfunction-or-prior-or-concurrent-malignancies/05aa2403-3ce3-4030-81d9-e59b704fd60c > FDA guidance document: Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies. Issue date: July 10, 2020. Get complete insights and analysis. --- ## Details - Title: Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies - Communication Type: Guidance Document - Product Type: biologics - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2020-07-10 - Last Changed: 2020-07-10 - Docket Number: FDA-2019-D-0359 ## Related Documents - [Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/d21a3c21-c758-4f3f-b215-edfe13aa09a3) - [Cancer Clinical Trial Eligibility Criteria: Minimum Age Considerations for Inclusion of Pediatric Patients](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-minimum-age-considerations-for-inclusion-of-pediatric-patients/3666fbd1-9a8e-4d1e-bc77-6f3feec9ce81) - [Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-patients-with-hiv-hepatitis-b-virus-or-hepatitis-c-virus-infections/4ebc5ded-b823-4045-9dc1-5e281b7b39f2)